WGS: Bathi resik saben saham (EPS TTM) GeneDx Holdings

By operating within the US jurisdiction, GeneDx Holdings Corp. (WGS) is shielded from geopolitical shocks. The rolling annual earnings per share snapshot demonstrates efficiency dynamics, where the value of -3.76 reflects the metric's balance. This complements its status as a pioneer in AI-driven exome sequencing for the diagnosis of rare pathologies. A powerful R&D unit drives this technological breakthrough, decoding DNA to advance personalized medicine.
Rincian metrik keuangan lan pasar Sema4 (WGS)

For GeneDx Holdings Corp. (WGS), the efficiency of scaling genomic testing and the control of IT infrastructure costs directly determine the dynamics of the trailing 12-month net income per share. This metric is calculated as the ratio of total net income over a rolling year to the number of shares outstanding, reflecting the actual business yield per share. Analyzing the trailing 12-month net income per share allows for an assessment of the company's ability to convert growing demand for diagnostics into fundamental capital.